Created at	Source	Raw Value	Validated value
July 1, 2021, 7 a.m.	eu	The primary study parameter is the antibody based immune response to vaccination against COVID-19 28 days after the second vaccination as compared to controls.	The primary study parameter is the antibody based immune response to vaccination against COVID-19 28 days after the second vaccination as compared to controls.